Evidence map›Paper›PMID 20443919›Full record

ArticleClinical and translational science2009

Imprinting status of Galpha(s), NESP55, and XLalphas in cell cultures derived from human embryonic germ cells: GNAS imprinting in human embryonic germ cells.

Janet L Crane, Michael J Shamblott, Joyce Axelman, Stephanie Hsu, Michael A Levine, Emily L Germain-Lee

Registry-linked trialAbstract read
In one paragraph

Article in Clinical and translational science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00209235 (Natural History Study of Albright Hereditary Osteodystrophy), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00209235 naactive not recruitingnot on this map

Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy

TypeinterventionalSponsorConnecticut Children's Medical CenterRan2003 to 2030Enrolled600ConditionsPseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy, PseudopseudohypoparathyroidismArmsNeurocognitive and psychosocial testing
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Syndromic Disorders Caused by Disturbed Human ImprintingJournal of clinical research in pediatric endocrinology · 2020
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Janet L CraneDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Michael J Shamblott
Joyce Axelman
Stephanie Hsu
Michael A Levine
Emily L Germain-Lee
Johns Hopkins University · USChildren's Hospital of Philadelphia · USKennedy Krieger Institute · US

Funding

SHORT-TERM TRAINING FOR MINORITY STUDENTST35HD007446 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI GORDON, CATHERINE M. · 1993 to 2014
$1.8M
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENER01DK056178 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEVINE, MICHAEL ALAN · 1999 to 2003
$1.6M
NICHD NIH HHS T-35 HD007446NICHD NIH HHS T35 HD007446NIDDK NIH HHS R01 DK056178
6 · The paper itself

Abstract

GNAS is a complex gene that through use of alternative first exons encodes signaling proteins Galpha(s) and XLalphas plus neurosecretory protein NESP55. Tissue-specific expression of these proteins is regulated through reciprocal genomic imprinting in fully differentiated and developed tissue. Mutations in GNAS account for several human disorders, including McCune-Albright syndrome and Albright hereditary osteodystrophy, and further knowledge of GNAS imprinting may provide insights into variable phenotypes of these disorders. We therefore analyzed expression of Galpha(s), NESP55, and XLalphas prior to tissue differentiation in cell cultures derived from human primordia germ cells. We found that the expression of Galpha(s) was biallelic (maternal allele: 52.6%+/- 2.5%; paternal allele: 47.2%+/- 2.5%; p= 0.07), whereas NESP55 was expressed preferentially from the maternal allele (maternal allele: 81.9%+/- 10%; paternal allele: 18.1%+/- 10%; p= 0.002) and XLalphas was preferentially expressed from the paternal allele (maternal allele: 2.7%+/- 0.3%; paternal allele: 97.3%+/- 0.3%; p= 0.007). These results demonstrate that imprinting of NESP55 occurs very early in development, although complete imprinting appears to take place later than 5-11 weeks postfertilization, and that imprinting of XLalphas occurs very early postfertilization. By contrast, imprinting of Galpha(s) most likely occurs after 11 weeks postfertilization and after tissue differentiation.

Indexed as

Gene Expression RegulationGenomic ImprintingAllelesChromograninsChromosome MappingDNA MethylationEmbryonic Stem CellsEpigenesis, GeneticFemaleGTP-Binding Protein alpha Subunits, GsHumansMaleModels, GeneticMutationTime FactorsChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, Gs

Identifiers

PMID20443919
PMCPMC4434047
OpenAlexW2119290569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.